BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 9861225)

  • 1. Enzyme replacement therapy for Gaucher's disease: the early Canadian experience.
    MacKenzie JJ; Amato D; Clarke JT
    CMAJ; 1998 Nov; 159(10):1273-8. PubMed ID: 9861225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The health-related quality of life of adults with Gaucher's disease receiving enzyme replacement therapy: results from a retrospective study.
    Damiano AM; Pastores GM; Ware JE
    Qual Life Res; 1998 Jul; 7(5):373-86. PubMed ID: 9691718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Enzyme therapy in children with severe forms of Gaucher's disease].
    Zeman J; Hrebícek M; Vepreková L; Kytnarová J; Houstková H; Malinová V; Hodanová K; Poupĕtová H; Ledvinová J; Hoza J
    Cas Lek Cesk; 1997 Feb; 136(3):95-7. PubMed ID: 9221177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Managing public payment for high-cost, high-benefit treatment: enzyme replacement therapy for Gaucher's disease in Ontario.
    Clarke JT; Amato D; Deber RB
    CMAJ; 2001 Sep; 165(5):595-6. PubMed ID: 11563212
    [No Abstract]   [Full Text] [Related]  

  • 5. Semiquantitative assessment of skeletal response to enzyme replacement therapy for Gaucher's disease using the bone marrow burden score.
    Robertson PL; Maas M; Goldblatt J
    AJR Am J Roentgenol; 2007 Jun; 188(6):1521-8. PubMed ID: 17515371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A less costly regimen of alglucerase to treat Gaucher's disease.
    Figueroa ML; Rosenbloom BE; Kay AC; Garver P; Thurston DW; Koziol JA; Gelbart T; Beutler E
    N Engl J Med; 1992 Dec; 327(23):1632-6. PubMed ID: 1435900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alglucerase. A review of its therapeutic use in Gaucher's disease.
    Whittington R; Goa KL
    Drugs; 1992 Jul; 44(1):72-93. PubMed ID: 1379912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzyme replacement therapy decreases hypergammaglobulinemia in Gaucher's disease.
    Deibener J; Kaminsky P; Jacob C; Dousset B; Klein M; Duc M
    Haematologica; 1998 May; 83(5):479-80. PubMed ID: 9658738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurological features in Gaucher's disease during enzyme replacement therapy.
    Ono H; Fujiwara M; Ito K; Ueda H; Mizoguchi N; Sakura N
    Acta Paediatr; 2001 Feb; 90(2):229-31. PubMed ID: 11236058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gaucher's disease in Lithuania: its diagnosis and treatment.
    Kleinotienė G; Tylki-Szymanska A; Czartoryska B
    Medicina (Kaunas); 2011; 47(7):405-11. PubMed ID: 22112991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gaucher's disease: a review.
    Morales LE
    Ann Pharmacother; 1996 Apr; 30(4):381-8. PubMed ID: 8729893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uveitis in Gaucher disease.
    Dweck A; Rozenman J; Ronen S; Zimran A; Elstein D
    Am J Ophthalmol; 2005 Jul; 140(1):146-7. PubMed ID: 16038664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Replacement therapy for inherited enzyme deficiency--macrophage-targeted glucocerebrosidase for Gaucher's disease.
    Barton NW; Brady RO; Dambrosia JM; Di Bisceglie AM; Doppelt SH; Hill SC; Mankin HJ; Murray GJ; Parker RI; Argoff CE
    N Engl J Med; 1991 May; 324(21):1464-70. PubMed ID: 2023606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gaucher's disease--ocular manifestation and treatment].
    Filipek E; Koraszewska-Matuszewska B
    Klin Oczna; 2006; 108(7-9):357-60. PubMed ID: 17290842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Echocardiographic assessment of pulmonary hypertension in Gaucher's disease.
    Elstein D; Klutstein MW; Lahad A; Abrahamov A; Hadas-Halpern I; Zimran A
    Lancet; 1998 May; 351(9115):1544-6. PubMed ID: 10326537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gaucher's disease and fatal hepatic fibrosis despite prolonged enzyme replacement therapy.
    Perel Y; Bioulac-Sage P; Chateil JF; Trillaud H; Carles J; Lamireau T; Guillard JM
    Pediatrics; 2002 Jun; 109(6):1170-3. PubMed ID: 12042560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gaucher disease: progressive mesenteric and mediastinal lymphadenopathy despite enzyme therapy.
    Burrow TA; Cohen MB; Bokulic R; Deutsch G; Choudhary A; Falcone RA; Grabowski GA
    J Pediatr; 2007 Feb; 150(2):202-6. PubMed ID: 17236903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Taliglucerase alfa for the treatment of Gaucher's disease.
    Haddley K
    Drugs Today (Barc); 2012 Aug; 48(8):525-32. PubMed ID: 22916340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical outcomes of 2 pediatric patients with Gaucher's disease in enzyme replacement therapy for 9 years].
    Quijada Fraile P; Martín Hernández E; Teresa García-Silva M
    Med Clin (Barc); 2011 Sep; 137 Suppl 1():43-5. PubMed ID: 22230125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [French results of enzyme replacement therapy in Gaucher's disease].
    Schaison G; Caubel I; Belmatoug N; Billette de Villemeur T; Saudubray JM
    Bull Acad Natl Med; 2002; 186(5):851-61; discussion 861-3. PubMed ID: 12412377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.